{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:00:12Z","timestamp":1780966812472,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.exer.2026.111063","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:30:17Z","timestamp":1778729417000},"page":"111063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dual TSHR\/IGF-1R\u03b1 electroporation induces progressive orbital remodeling and retinochoroidal alterations in a murine model of thyroid eye disease"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8336-1957","authenticated-orcid":false,"given":"Panpan","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.exer.2026.111063_bib1","first-page":"776","article-title":"Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy","volume":"85","author":"Aniszewski","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.exer.2026.111063_bib2","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1210\/jc.2004-0977","article-title":"High levels of circulating CXC chemokine ligand 10 are associated with chronic autoimmune thyroiditis and hypothyroidism","volume":"89","author":"Antonelli","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.exer.2026.111063_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1530\/eje.1.01847","article-title":"Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis","volume":"152","author":"Antonelli","year":"2005","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.exer.2026.111063_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/IJG.0b013e31802e644b","article-title":"Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy","volume":"16","author":"Behrouzi","year":"2007","journal-title":"J. Glaucoma"},{"issue":"5","key":"10.1016\/j.exer.2026.111063_bib5","first-page":"277","article-title":"Retina and nerve fiber layer thickness in eyes with thyroid-associated ophthalmopathy","volume":"19","author":"Blum Meirovitch","year":"2017","journal-title":"Isr. Med. Assoc. J."},{"key":"10.1016\/j.exer.2026.111063_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5891531","article-title":"The increment of choroidal thickness in euthyroid graves' ophthalmopathy: is it an early sign of venous congestion?","volume":"2018","author":"Cagiltay","year":"2018","journal-title":"J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2026.111063_bib7","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/01676830.2020.1846761","article-title":"Retinal vascularity, nerve fiber, and ganglion cell layer thickness in thyroid eye disease on optical coherence tomography angiography","volume":"41","author":"Dave","year":"2022","journal-title":"Orbit"},{"issue":"5","key":"10.1016\/j.exer.2026.111063_bib8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00417-020-04616-9","article-title":"Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and Angio-OCT","volume":"258","author":"Del Noce","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"3","key":"10.1016\/j.exer.2026.111063_bib9","article-title":"Time-serial evaluation of the development and treatment of myopia in mice eyes using OCT and ZEMAX","volume":"13","author":"Ding","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"6","key":"10.1016\/j.exer.2026.111063_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/bjo.2003.035915","article-title":"Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression","volume":"88","author":"Eckstein","year":"2004","journal-title":"Br. J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.exer.2026.111063_bib11","first-page":"522","article-title":"Preliminary study on the correlation between episcleral venous pressure and intraocular pressure in TAO patients and its clinical value","volume":"30","author":"Fan","year":"2024","journal-title":"Alternative Ther. Health Med."},{"issue":"5","key":"10.1016\/j.exer.2026.111063_bib12","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s40123-024-00912-3","article-title":"Effect of intraorbital mechanical compression on retinal microvascular perfusion in quiescent thyroid-associated ophthalmopathy based on ocular biomechanics measured by corvis ST","volume":"13","author":"Fang","year":"2024","journal-title":"Ophthalmol. Ther."},{"key":"10.1016\/j.exer.2026.111063_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101898","article-title":"Evaluation of choroidal thickness and retinal vessel density in patients with inactive graves' orbitopathy","volume":"32","author":"Fazil","year":"2020","journal-title":"Photodiagnosis Photodyn. Ther."},{"issue":"4","key":"10.1016\/j.exer.2026.111063_bib14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2353\/ajpath.2006.060434","article-title":"Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes","volume":"169","author":"Feldon","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"17","key":"10.1016\/j.exer.2026.111063_bib15","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1038\/s41433-023-02580-2","article-title":"Alterations in retrobulbar haemodynamics in thyroid eye disease","volume":"37","author":"Goel","year":"2023","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.exer.2026.111063_bib16","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.survophthal.2023.01.003","article-title":"Orbital and ocular perfusion in thyroid eye disease","volume":"68","author":"Goel","year":"2023","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111063_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41433-021-01453-w","article-title":"The changes of retinal nerve fibre layer and ganglion cell layer with different severity of thyroid eye disease","volume":"36","author":"Guo","year":"2022","journal-title":"Eye (Lond)"},{"issue":"8","key":"10.1016\/j.exer.2026.111063_bib18","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41433-022-02142-y","article-title":"Changes in retinal nerve fibre layer, ganglion cell layer and visual function in eyes with thyroid eye disease of different severities with and without orbital decompression","volume":"37","author":"Guo","year":"2023","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.exer.2026.111063_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/en.2005-1018","article-title":"T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy","volume":"147","author":"Han","year":"2006","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.exer.2026.111063_bib20","first-page":"10","article-title":"Clinical analysis of 106 cases with elevated intraocular pressure in thyroid-associated ophthalmopathy","volume":"20","author":"He","year":"2004","journal-title":"Yan Ke Xue Bao"},{"issue":"1","key":"10.1016\/j.exer.2026.111063_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/01676830.2013.851252","article-title":"No light perception vision from compressive thyroid orbitopathy","volume":"33","author":"Hornbeak","year":"2014","journal-title":"Orbit"},{"issue":"6","key":"10.1016\/j.exer.2026.111063_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23062918","article-title":"Sodium-iodate injection can replicate retinal degenerative disease stages in pigmented mice and rats: non-invasive Follow-Up using OCT and ERG","volume":"23","author":"Koster","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.exer.2026.111063_bib23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jc.2014-3566","article-title":"Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by graves' disease immunoglobins","volume":"100","author":"Krieger","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.exer.2026.111063_bib24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archopht.1966.03850010246017","article-title":"Dysthyroid ocular myopathy. Anatomy, histology, and electron microscopy","volume":"76","author":"Kroll","year":"1966","journal-title":"Arch. Ophthalmol."},{"issue":"7","key":"10.1016\/j.exer.2026.111063_bib25","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/ceo.13525","article-title":"Choroidal thickness in thyroid-associated orbitopathy","volume":"47","author":"Lai","year":"2019","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"2","key":"10.1016\/j.exer.2026.111063_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101620","article-title":"Pathophysiology of thyroid-associated orbitopathy","volume":"37","author":"Lee","year":"2023","journal-title":"Best Pract. Res. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.exer.2026.111063_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2478314","article-title":"Retinal and choroidal microvascular analysis by swept-source optical coherence tomography angiography in thyroid-associated ophthalmopathy (TAO) and hyperthyroidism without clinical signs of TAO","volume":"57","author":"Liang","year":"2025","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.exer.2026.111063_bib28","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1177\/11206721211062030","article-title":"Retinal nerve fiber layer and ganglion cell complex thickness as a diagnostic tool in early stage dysthyroid optic neuropathy","volume":"32","author":"Luo","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2026.111063_bib29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1089\/thy.2021.0176","article-title":"Mechanisms in graves eye disease: apoptosis as the end point of insulin-like growth factor 1 receptor inhibition","volume":"32","author":"Morshed","year":"2022","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.exer.2026.111063_bib30","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.4049\/jimmunol.168.6.2789","article-title":"A novel murine model of graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor","volume":"168","author":"Nagayama","year":"2002","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.exer.2026.111063_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2019.151902","article-title":"Insulin-like growth factor-1 enhances the expression of functional TSH receptor in orbital fibroblasts from thyroid-associated ophthalmopathy","volume":"225","author":"Paik","year":"2020","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.exer.2026.111063_bib32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/bph.13693","article-title":"Inhibiting thyrotropin\/insulin-like growth factor 1 receptor crosstalk to treat graves' ophthalmopathy: studies in orbital fibroblasts in vitro","volume":"174","author":"Place","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.exer.2026.111063_bib33","first-page":"673","article-title":"The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocr. Rev."},{"issue":"12","key":"10.1016\/j.exer.2026.111063_bib34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1055\/a-0725-9297","article-title":"Reflections on thyroid autoimmunity: a personal overview from the past into the future","volume":"50","author":"Rapoport","year":"2018","journal-title":"Horm. Metab. Res."},{"issue":"11","key":"10.1016\/j.exer.2026.111063_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202511078","article-title":"Fluoropolymer-mediated delivery of a dual TSHR\/IGF1R-Targeting CRISPR-Cas9 system for localized therapy in thyroid-associated ophthalmopathy","volume":"38","author":"Shi","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.exer.2026.111063_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1392956","article-title":"Immune checkpoints: new insights into the pathogenesis of thyroid eye disease","volume":"15","author":"Shu","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.exer.2026.111063_bib37","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/13543784.2020.1772752","article-title":"Teprotumumab: a novel therapeutic monoclonal antibody for thyroid-associated ophthalmopathy","volume":"29","author":"Slentz","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.exer.2026.111063_bib38","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/jcem.87.1.8164","article-title":"Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy","volume":"87","author":"Smith","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.exer.2026.111063_bib39","first-page":"3428","article-title":"Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture","volume":"81","author":"Sorisky","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.exer.2026.111063_bib40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1677\/jme.0.0300369","article-title":"Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo","volume":"30","author":"Starkey","year":"2003","journal-title":"J. Mol. Endocrinol."},{"issue":"2","key":"10.1016\/j.exer.2026.111063_bib41","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3897\/folmed.62.e47689","article-title":"Ocular hypertension, glaucoma or compressive neuropathy in patient with active TED","volume":"62","author":"Stoyanova","year":"2020","journal-title":"Folia Med. (Plovdiv)"},{"key":"10.1016\/j.exer.2026.111063_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-205824","article-title":"Aqueous misdirection in thyroid eye disease","volume":"2014","author":"Tripathy","year":"2014","journal-title":"BMJ Case Rep."},{"issue":"6","key":"10.1016\/j.exer.2026.111063_bib43","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.exer.2026.111063_bib44","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s10792-024-03111-y","article-title":"Vascular changes of the peripapillary choroidal area in the thyroid orbitopathy","volume":"44","author":"Unlu","year":"2024","journal-title":"Int. Ophthalmol."},{"issue":"7","key":"10.1016\/j.exer.2026.111063_bib45","first-page":"2557","article-title":"Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor","volume":"84","author":"Valyasevi","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.exer.2026.111063_bib46","first-page":"592","article-title":"Immunotherapy with a biologically active ICAM-1 mAb and an siRNA targeting TSHR in a BALB\/c mouse model of Graves' disease","volume":"72","author":"Wang","year":"2021","journal-title":"Endokrynol. Pol."},{"issue":"26","key":"10.1016\/j.exer.2026.111063_bib47","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM197406272902602","article-title":"Ultrasonographic evidence of a consistent orbital involvement in Graves's disease","volume":"290","author":"Werner","year":"1974","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.exer.2026.111063_bib48","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S2213-8587(25)00066-X","article-title":"Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management","volume":"13","author":"Wiersinga","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"11","key":"10.1016\/j.exer.2026.111063_bib49","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1007\/s11517-022-02663-4","article-title":"DMs-MAFM+EfficientNet: a hybrid model for predicting dysthyroid optic neuropathy","volume":"60","author":"Wu","year":"2022","journal-title":"Med. Biol. Eng. Comput."},{"issue":"10","key":"10.1016\/j.exer.2026.111063_bib50","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s40618-024-02344-z","article-title":"Mouse model of Graves' orbitopathy induced by the immunization with TSHR A and IGF-1R\u03b1 subunit gene","volume":"47","author":"Wu","year":"2024","journal-title":"J. Endocrinol. Investig."},{"issue":"5","key":"10.1016\/j.exer.2026.111063_bib51","first-page":"911","article-title":"CD4+ T cells and the Th1\/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy","volume":"17","author":"Xia","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.exer.2026.111063_bib52","doi-asserted-by":"crossref","DOI":"10.1007\/s13167-026-00435-w","article-title":"The predictive, preventive, and personalised medicine of thyroid eye disease: a comprehensive guide to risk minimization","author":"Zhang","year":"2026","journal-title":"EPMA J."},{"issue":"4","key":"10.1016\/j.exer.2026.111063_bib53","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/thy.2020.0088","article-title":"A promising mouse model of graves' orbitopathy induced by adenovirus expressing thyrotropin receptor A subunit","volume":"31","author":"Zhang","year":"2021","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.exer.2026.111063_bib54","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1210\/clinem\/dgaf230","article-title":"A preclinical state of graves' ophthalmopathy characterized by hypoxia of T-cells identified via multiomics analysis","volume":"110","author":"Zhang","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.exer.2026.111063_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2528046","article-title":"Cytokines in thyroid-associated ophthalmopathy","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Immunol. Res."},{"issue":"4","key":"10.1016\/j.exer.2026.111063_bib56","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3892\/mmr.2017.6181","article-title":"An improved method for the establishment of a model of graves' disease in BALB\/c mice","volume":"15","author":"Zheng","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"8","key":"10.1016\/j.exer.2026.111063_bib57","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bjo-2023-323694","article-title":"Choroidal thickness in patients with thyroid-associated ophthalmopathy, as determined by swept-source optical coherence tomography","volume":"108","author":"Zhong","year":"2024","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.111063_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2023-001443","article-title":"Increased choroidal stromal area in patients with active graves' ophthalmopathy based on binarisation method of optical coherence tomographic images","volume":"9","author":"Zhou","year":"2024","journal-title":"BMJ Open Ophthalmol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526002198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:32:20Z","timestamp":1780965140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526002198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":58,"alternative-id":["S0014483526002198"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.111063","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual TSHR\/IGF-1R\u03b1 electroporation induces progressive orbital remodeling and retinochoroidal alterations in a murine model of thyroid eye disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.111063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111063"}}